Results 41 to 50 of about 9,985 (145)
Paediatric Acute Generalised and Localised Exanthematous Pustulosis: A Systematic Review
JEADV Clinical Practice, Volume 5, Issue 2, Page 678-681, June 2026.
Miranda K. Branyiczky +6 more
wiley +1 more source
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau +62 more
wiley +1 more source
An immunomodulatory activity of micafungin in preclinical aspergillosis
, 2014 Objectives: Micafungin inhibits 1,3-b-D-glucan synthase and interferes with fungal cell wall synthesis. Clinically, micafungin has been shown to be efficacious for the treatment of invasive fungal infections.
AVERSA, Franco +7 more
core +1 more source
VIEW, Volume 7, Issue 2, April 2026.Pulmonary fungal infections are life‐threatening complications in lung cancer patients, posing significant challenges in clinical management. To address this, we developed machine learning tools that translate routine electronic health record data into actionable insights for diagnosing infections and assessing prognosis.
Hongwei Meng +14 more
wiley +1 more source
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
, 2009 Nathan P Wiederhold1, Jason M Cota2, Christopher R Frei11University of Texas at Austin College of Pharmacy, Austin, Texas, USA; 2University of the Incarnate Word Feik School of Pharmacy, San Antonio, Texas, USAAbstract: Micafungin is an echinocandin ...
Christopher R Frei +2 more
core
The Epidemiology and Infection Control of Candida Auris in Shanghai
Mycoses, Volume 69, Issue 4, April 2026.ABSTRACT Background Candida auris is a globally emerging multidrug‐resistant fungus. Its dissemination is driven by patient movement and asymptomatic carriers. However, molecular epidemiological studies linking imported cases to local strains in large metropolitan areas remain limited.
Mingjing Wei +8 more
wiley +1 more source
Pharmacokinetics of Micafungin in Critically Ill Patients [PDF]
, 2019 We investigated covariates of pharmacokinetics of micafungin in critically ill patients. After application of micafungin, plasma samples were collected. Non-linear mixed effects modelling (NONMEM 7.3) was used to develop the pharmacokinetic model.
Lanckohr, C +7 more
core
Review of the pharmacology and clinical studies of micafungin
, 2009 Alison M Bormann1, Vicki A Morrison21Division of Infectious Diseases, University of Minnesota, Minneapolis, MN, USA; 2Division of Hematology/Oncology and Infectious Disease, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USAAbstract ...
Vicki A Morrison, Alison M Bormann
core
, 2014 To explore the pharmacokinetics (PK) and pharmacodynamics (PD) of micafungin in patients undergoing continuous venovenous haemofiltration (CVVH)
Luque, Sonia +15 more
core +1 more source
Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
, 2023 Echinocandin antifungal drugs, including micafungin, anidulafungin, and caspofungin, have been recently reported to exhibit antiviral effects against various viruses such as flavivirus, alphavirus, and coronavirus. In this study, we focused on micafungin
Shogo Nakajima +6 more
core +1 more source